Back
Genmab A/S Vs. Ascendis Pharma A/S Industry Stock Comparison
Buy
53
GNMSF
Genmab A/S
Last Price:
301.97
Seasonality Move:
9.07%
Sell
35
ASND
Ascendis Pharma A/S
Last Price:
122.87
Seasonality Move:
2.88%
Buy
53
Genmab A/S (GNMSF)
is a Buy
Is Genmab A/S a Buy, Sell or Hold?
- The current Genmab A/S [GNMSF] share price is $291.54. The Score for GNMSF is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- GNMSF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy, Sell or Hold?
- The current Ascendis Pharma A/S [ASND] share price is $124.04. The Score for ASND is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GNMSF Stock Price Chart
What is Genmab A/S's stock price today?
-
The Genmab A/S share price today is $291.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GNMSF is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma A/S's stock price today?
-
The Ascendis Pharma A/S share price today is $124.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
GNMSF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 53.59 | Buy |
Chaikin Money Flow: | -27 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (276.2 - 291.46) | Buy |
Bollinger Bands (100): | (277.14 - 306.26) | Sell |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.57 | Sell |
Relative Strength Index (14 RSI): | 27.73 | Sell |
Chaikin Money Flow: | -836005 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.25 - 144.49) | Sell |
Bollinger Bands (100): | (132.02 - 150.42) | Sell |
GNMSF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 286.78 | Buy |
20-day SMA: | 282.92 | Buy |
50-day SMA: | 291.6 | Sell |
200-day SMA: | 315.27 | Sell |
8-day EMA: | 286.2 | Buy |
20-day EMA: | 285.31 | Buy |
50-day EMA: | 288.19 | Buy |
200-day EMA: | 313.27 | Sell |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.41 | Sell |
20-day SMA: | 136.66 | Sell |
50-day SMA: | 143.53 | Sell |
200-day SMA: | 118.89 | Buy |
8-day EMA: | 130.67 | Sell |
20-day EMA: | 135.77 | Sell |
50-day EMA: | 139.83 | Sell |
200-day EMA: | 125.66 | Sell |
Genmab A/S Earnings Growth & GNMSF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.35 per share, an increase next quarter of $1.16 per share, an increase this year of $4.20 per share, and an increase next year of $4.63 per share.
Genmab A/S Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma A/S Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |